Blood Factor Contamination Cases
Result: Confidential settlements
Year: 2009
Blood Factor VIII and Factor IX Litigation
Working with counsel in Asia, Europe, Central and South America and the Middle East, Lieff Cabraser represented over 1500 of hemophiliacs worldwide, or their survivors and estates, who contracted HIV and/or Hepatitis C (HCV), and Americans with hemophilia who contracted HCV, from contaminated and defective blood factor products produced by American pharmaceutical companies. In 2004, Lieff Cabraser was appointed Plaintiffs’ Lead Counsel of the “second generation” Blood Factor MDL litigation presided over by Judge Grady in the Northern District of Illinois. The case reached a global settlement in 2009.
Civil Litigation News
Mark Chalos Selected as Co-Lead Counsel for Plaintiffs in Generac Solar Power Systems Marketing Practice and Products Liability Litigation
The Generac Solar Energy Systems litigation focuses on allegations that energy tech giant Generac’s PWRECell System components are defective and potentially dangerous
Sarah London Testifies Before the CA State Assembly in Support of Bill to Stop Corporate Arbitration Abuse in California
On June 13, 2023, Lieff Cabraser partner Sarah London testified before the California State Assembly in support of SB 365. The bill,
Lieff Cabraser Announces Historic $235M Comprehensive Settlement with Altria in National JUUL Youth E-Cigarette Predatory Advertising, Addiction and Injury Cases
Unprecedented in scope, speed, and significance, the global settlement, reached just after plaintiffs concluded their case in the bellwether trial in San
